Possibilities of minimally invasive surgery for large atrial septal defects
Abstract
Aim. Study and proof of the possibilities of minimally invasive surgery for large atrial septal defects.
Material and methods. In the period between 2010 and 2012 33 adult patients with atrial septal defect (ASD) with ASD 34-40 мм (mean 35.3±2.1) were operated on. According to the ECHO-Cs data, pulmonary hypertension with systolic pressure from 35 to 120 mm Hg was detected at admission in all patients (mean 45.39±18.6 mm). All patients underwent endovascular implantation of the occluder ASD (atrium septum defect) with transfemoral access.
Results. All DMPs were occluded in x-ray surgery. Each patient was implanted with two-disc occluders of ASD type. The postoperative follow-up period was 8 years. There were no dislocation of the occluder, protrusion of the edges of the ASD and thrombosis of the device at follow up period. The main advantages of this technique that the operation is performed without anesthesia, incision and cardiopulmonary bypass (IC), there is always the possibility of reimplantation, repositioning of the device.
Conclusion. Endovascular treatment of atrial septal defect by implantation of an occlusive device is a highly effective and safe procedure.
Keywords:congenital heart disease, atrial septal defect, implantation of occlusive devices, pulmonary hypertension, endovascular treatment
For citation: Korzh D.A., Samko A.N., Gorbunov M.G., Gaponov D.P., Larionov A.A., Tkachev V.I., Kuznetsov S.A., Tarasov D.G. Possibilities of minimally invasive surgery for large atrial septal defects. Clin Experiment Surg. Petrovsky J. 2019; 7 (1): 69–72. doi: 10.24411/2308-1198-2019-11009. (in Russian)
Received 20.11.2018. Accepted 06.02.2019.
References
1. King N.D., Mills N. Secundum atrial septal de- fects: nonoperative closure during cardiac catheterization. JAMA. 1976; 235: 2506–9.
2. Alekyan B.G., Petrosyan Y.S., Gharibyan V.A., et al. Endovascular surgery in the treatment of congenital heart defects. Annaly khirurgii [Annals of Surgery]. 1996; 3: 54–63. (in Russian)
3. Das O.S., Voss G., Jamis G., et al. Experimental atrial defect closure with a new, trancatheter, self-centering device. Circulation. 1993; 88: 1754–64.
4. Schneider M., Babic J., Franzbach B., Hausdorf G. Transcatether closure of secundum atrial septal defect with the ASDOS device in children. J Am Coll Cardiol. 1996; 27 (A): 119A.
5. Masura J., GauoraP., Formenefc A., Hyazi Z.M. Transcatether closure of secundum atrial septal defects using the new self-cenetring Amplatzer septal occlude: initial human experience. Cathet Cardiovasc Diagn. 1997; 42: 388–93.
6. Latson L.A., Zahn E.M., Wilson N. Helex septal oc- cluder for closure of atrial septal defect. Curr Interv. Car- diol. Rep.2000; 2: 268–73.
7. Alekyan B.G. Congenital malformations of the heart. Manual in 4 vol. Vol. 1. 348 p. Moscow: Litterra, 2017. 576 p.(in Russian)
8. Korzh D.A., Gorbunov M.G., Larionov A.A., Ga- ponov D.P., et al. Endovascular treatment of atrial septal defect with deficiency of the aortic region. Clin Experiment Surg. Petrovsky J. 2018; 6 (1): 39–43. (in Russian)
9. Zwijnenburg R.D., Baggen V.J.M., Geenen L.W., Voigt K.R., et al. The prevalence of pulmonary arterial hypertension before and atrial septal defect closure at adult age: a systematic review. Am Heart J. 2018; 201: 63–71. doi: 10.1016/j.ahj.2018.03.020. Epub 2018 Apr 6.
10. Sideris E.B., Leung M., Yoon J.H., Chen C.R., et al. Occlusion of large atrial septal defects with a centering buttoned device: early clinical experience. Am Heart J. 1996; 131 (2): 356–9.